期刊文献+

Ang-1在多发性骨髓瘤患者中的表达及临床意义 被引量:4

Expression and clinical significance of angiopoietin-1 in multiple myeloma
原文传递
导出
摘要 目的 研究血管生成素-1(angiopoietin-1,Ang-1)及其受体Tie-2在多发性骨髓瘤(MM)患者和骨髓瘤细胞株RPMI8226的表达情况,探讨其意义.方法 采用RT-PCR和Western blot方法检测112例MM患者、24例非肿瘤患者(对照组)以及RPMI8226细胞株中Ang-1及其受体Tie-2的表达水平,分析阳性率及表达水平在MM患者与对照组、MM不同分期间的差异,探讨Ang-1表达与MM患者骨髓微血管密度、临床分期及预后的关系.结果 MM组Ang-1表达阳性率、表达水平均显著高于对照组(P<0.05);Ang-1表达阳性率在初治组和复发/难治MM组的差异无统计学意义(P>0.05),但复发/难治MM组的Ang-1表达水平高于初治组(P<0.05);Tie-2 mRNA仅在12例MM患者中检出,对照组未检出.MM患者骨髓微血管密度(25.21±0.80)明显高于对照组(5.23±0.20)(P<0.01);Ang-1阳性患者的骨髓微血管密度(32.98±1.70)高于Ang-1阴性患者(16.55±1.30)(P<0.05);Ang-1表达阳性率在Ⅱ期和Ⅲ期MM患者中差异无统计学意义(52.1%对60.9%,P>0.05),但Ⅲ期MM患者Ang-1蛋白的表达水平(0.40±0.07)明显高于Ⅱ期患者(0.22±0.04)(P<0.05);初治患者中,治疗无效组Ang-1表达阳性率(70.0%)明显高于有效组(19.1%)(P<0.01).结论 Ang-1在MM患者中高表达;Ang-1表达与MM临床分期、预后判断及靶向治疗有关. Objective To study the expression of angiopoietin-1(Ang-1)and its receptor Tie-2 in multiple myeloma(MM)patients and RPMI8226 cells,and analyze the significance of Ang-1 expression and its relevance to the tumorigenes and development of MM.Methods RT-PCR and Western blot were used to detect the expression of Ang-1 and Tie-2 in bone marrow(BM)samples from 112 MM patients and 24 control subjects,and in RPMI8226 cells.The expression levels of Ang-1 in different groups and disease stages were analyzed.Results The positive rate and expression level of Ang-1 were significantly higher in MM group than in control group(P 〈0.05).The positive rates of Ang-1 were not significantly different between newly diagnosed and relapsed/refractory MM groups,but its expression level was significantly higher in the latter group than in the former group(P 〈0.05).Tie-2 was detected only in 12 MM patients and did not in control group and RPMI8226 cells.Microvessel density in BM samples were significantly higher in MM group than in control group(25.21±0.80 vs 5.23±0.20,P〈0.01),and were higher in Ang-1-positive MM group than in Ang-1-negative M M group(32.98 ± 1.70 vs 16.55 ± 1.30,P 〈 0.05).The positive rates of Ang-1 protein were not significantly different between stage Ⅱ and stage Ⅲ MM(52.1% vs 60.9%,P〉0.05),but the expression level of Ang-1 protein was higher in stage Ⅲ than that in stage Ⅱ MM(0.40 ±0.07 vs 0.22 ±0.04,P 〈0.05).In the newly diagnosed MM patients,the positive rate of Ang-1 protein in PD patients was significantly higher than in PR and MR patients(70.0% vs 19.1%,P 〈0.01).Conclusion High expression of Ang-1 is found in MM patients and RPMI8226 cells,and its expression is associated with the disease stage,prognosis and targeted therapy of MM.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2010年第10期654-658,共5页 Chinese Journal of Hematology
基金 河北省自然科学基金(C2008001097)
关键词 多发性骨髓瘤 血管生成素-1 血管生成素-1受体 血管内皮生长因子 Multiple myeloma Angiopoietin-1 Angiopoietin-1 receptor Vascular endothelial
  • 相关文献

参考文献2

二级参考文献13

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1379
  • 2丁友成,朱正纲,刘炳亚,纪玉宝,陈雪华,张奕,于颖彦,林言箴.胃癌细胞uPA表达与腹膜种植潜能的相关性研究[J].中华肿瘤杂志,2005,27(1):13-15. 被引量:10
  • 3Li Zhang,Zhong-Sheng Zhao,Guo-Qing Ru,Jie Ma.Correlative studies on uPA mRNA and uPAR mRNA expression with vascular endothelial growth factor, microvessel density, progression and survival time of patients with gastric cancer[J].World Journal of Gastroenterology,2006,12(25):3970-3976. 被引量:13
  • 4Marchuk DA. Pathogenesis of hemangiomal. J Clin Invest, 2001,107(6):665-666.
  • 5Boye E. Clonality and altered behabior of endothelial cells form hemanglomas. J Clin Invest, 2001,107(6):745-752.
  • 6Etoh T, lnoue H,Tanaka SJ,et al. Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma possible in vivo regulation via induction of proteases. Cancer Res, 2001, 61(1):2145-2153.
  • 7Malsonpiewe PC, Suri C, Jones PF, et al. Angiopoietin-2, a natural antagonist for tie-2 that disrupts in vivo angiogenesis. Science, 1997, 277(5322):55-60.
  • 8Holash J, Maisonpierre PC, Compton D, et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science, 1999,284(5422): 1994-1998.
  • 9Ying Yu, Joyce Varughese, Lawrence F, et al. Increased Tie2 expression, enhanced response to angiopoietin-1,and dysregulated anglopoietin-2 expression in hemangioma-derived endothelial cells. Am J Pathol,2001,159:2271-2280.
  • 10Dhar DK, Naora H, Yamanoi A, et al. Requisite role of VEGF receptors in angiogenesis of hepatocellular carcinoma: a comparison with angiopoietin/Tie pathway. Anticancer Res, 2002,22(1A):379-386.

共引文献14

同被引文献37

  • 1张真真,张声,林建银,黄培生,陈余鹏.促血管生成素及其受体的异常表达与胃癌血管生成的关系[J].中华肿瘤杂志,2006,28(4):280-284. 被引量:17
  • 2何立丽,张伟京,苏航,徐东刚.Ang-2与VEGF的协同作用及其在抗肿瘤血管新生治疗中的应用[J].中国实验血液学杂志,2007,15(2):445-448. 被引量:12
  • 3Bach F, Uddin FJ, Burke D. Angiopoietins in malignancy[J]. EJSO, 2007,33(1) :7-15.
  • 4Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors[J]. Breast Cancer Res Treat, 1995,36(2):169-180.
  • 5Yu Q, Stamenkvic I. Angiopietin-2 is implicated in the regulation of tumor angiogenesis[J]. Am J Pethol, 2001,158(2):563- 570.
  • 6Tang D, Nagano H, Yamamoto H, et al. Angiogenesis in cholangiocellular carcinoma.. Expression of vascular endothelial growth factor, angiopoietin-1/2, thrombospondin-1 and clinicopathological significance[J]. Oncol Rep, 2006,15 (3) : 525-532.
  • 7Moon SJ, Park HS, Yu KH, et al. Expression of Angiopoietin- 1,2 and their common receptor Tie2 in human gastric carcinoma: implication for angiogenesis[J]. J Korean Med Sci, 2006,21(2) : 272-278.
  • 8Zhang L, Yang N, Park JW, et al. Tumor derived vascular en dothelial growth factor up-Regulates angiopoietin-2 in host endo thelium and destabilizes host vasculature, Supporting Angiogen esis in Ovarian[J]. Cancer Res, 2003,63(12):3403-3412.
  • 9Wang J, Wu K, Zhang D, et al. Expressions and clinical significances of angiopoietin -1, -2 and Tie-2 in human gastric cancer [J]. Biochem Biophys Res Commun, 2005,337(1) :386-393.
  • 10Zhiyong C, Wentong L, Xiaoyang Y, et al. PTEN's regulation of VEGF and VEGFR1 expression and its clinical significance in myeloid leukemia[J]. Med Oncol, 2012, 29(2) : 1084 -1092.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部